{"title": "Anti-malarial shows promise in human clinical study", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/pharmaceuticals.xml", "value": "Anti-malarial shows promise in human clinical study"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/03/190311133112.htm"}], "link": "https://www.sciencedaily.com/releases/2019/03/190311133112.htm", "summary": "An experimental drug, called DSM265, cured seven volunteers of a Plasmodium falciparum infection, a malaria parasite that is a major cause of morbidity and mortality worldwide. The goal of this research is to find a cure for malaria with a single dose, and ultimately, eradicate the parasite.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/pharmaceuticals.xml", "value": "An experimental drug, called DSM265, cured seven volunteers of a Plasmodium falciparum infection, a malaria parasite that is a major cause of morbidity and mortality worldwide. The goal of this research is to find a cure for malaria with a single dose, and ultimately, eradicate the parasite."}, "published": "Mon, 11 Mar 2019 13:31:12 EDT", "published_parsed": [2019, 3, 11, 17, 31, 12, 0, 70, 0], "id": "https://www.sciencedaily.com/releases/2019/03/190311133112.htm", "guidislink": false}